Delivered Total and Net Investment Income of $36.7 million and $15.9 million, RespectivelyInvestment Portfolio of $1.1 billionConference Call Today, Tuesday, November 12, 2024, at 5:00 p.m. ET MENLO ...
Completed enrollment of Phase 2 BESTOW trial of tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Announced positive ini ...
ASX-listed Lake Resources on Wednesday announced a sale agreement with Austroid Corporation to sell three of its lithium ...